Paper39619170
Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study.
Zhao Y and 5 others. Oncol Lett, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study. Papers, record 39619170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39619170
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preoperative D‑dimer level and prognosis in patients diagnosed with gastric cancer and undergoing gastric cancer radical surgery: A retrospective cohort study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26811653 | Advanced gastric cancer: What we know and what we still have to learn. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26811653 | PubMed |
| 2 | 19377917 | Activation of clotting factors in cancer. | Cancer Treat Res | 2009 | https://conductscience.org/library/papers/19377917 | PubMed |
| 3 | 19584268 | Platelets: guardians of tumor vasculature. | Cancer Res | 2009 | https://conductscience.org/library/papers/19584268 | PubMed |
| 4 | 29577550 | Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomized, double-blind, placebo-controlled clinical trial. | Diabetes Obes Metab | 2018 | https://conductscience.org/library/papers/29577550 | PubMed |
| 5 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 6 | 31585123 | Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations. | Gastroenterology | 2019 | https://conductscience.org/library/papers/31585123 | PubMed |
| 7 | 35646964 | A Novelly Developed Bipolar Needle Knife Can Be an Alternative Device Choice for Endoscopic Submucosal Dissection (With Video). | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/35646964 | PubMed |
| 8 | 35274004 | Pan-Cancer Analysis and Validation Reveals that D-Dimer-Related Genes are Prognostic and Downregulate CD8+ T Cells via TGF-Beta Signaling in Gastric Cancer. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35274004 | PubMed |
| 9 | 22826226 | Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22826226 | PubMed |
| 10 | 34260413 | Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34260413 | PubMed |
| 11 | 24781600 | Preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer. | Surg Today | 2015 | https://conductscience.org/library/papers/24781600 | PubMed |
| 12 | 34830011 | Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830011 | PubMed |
| 13 | 30207593 | Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/30207593 | PubMed |
| 14 | 34934895 | Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study. | Res Pract Thromb Haemost | 2021 | https://conductscience.org/library/papers/34934895 | PubMed |
| 15 | 34855203 | Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. | Int J Cancer | 2022 | https://conductscience.org/library/papers/34855203 | PubMed |
| 16 | 30485589 | Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30485589 | PubMed |
| 17 | 25759537 | Stratifying the risk of lymph node metastasis in undifferentiated-type early gastric cancer. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25759537 | PubMed |
| 18 | 27160890 | Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. | Surg Today | 2016 | https://conductscience.org/library/papers/27160890 | PubMed |
| 19 | 29736307 | A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/29736307 | PubMed |
| 20 | 35183058 | LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis. | Aging (Albany NY) | 2022 | https://conductscience.org/library/papers/35183058 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39619170
GET https://conductscience.org/api/papers/v1/39619170/references?page=2